Design, synthesis, biological activities, and evaluation of molecular docking‐dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease
- 18 September 2023
- journal article
- research article
- Published by Wiley in Journal of Molecular Recognition
- Vol. 36 (12) , e3059
Abstract
Donepezil is one of the most used drugs in the treatment of Alzheimer's disease. Its activity as an AChE inhibitor makes new studies with these enzyme inhibitors attractive. For this purpose, in this study, 12 compounds including thiosemicarbazone pharmacophore, have been synthesized for the treatment of the Alzheimer's disease. 3,4‐Dimethoxybenzene or 1,3‐benzodioxolone rings were used for the PAS region. The substituted piperazine benzene structure is preferred for the CAS region. At the same time, the thiosemicarbazone pharmacophore structure with known ChE enzyme inhibition potential was used as a bridge connecting the CAS and PAS regions. Structure determination of compounds 3a–3l were revealed using 13C‐NMR, 1H‐NMR, and HRMS spectroscopic methods. The inhibition profile of obtained compounds (3a–3l) against ChE was evaluated using in vitro modified Ellman method. Compounds 3a, 3b, 3f, 3g and 3i exhibited inhibitory activity against the AChE enzyme. Compound 3a showed the highest inhibitory potential with an IC50 = 0.030 ± 0.001 μM. As a result of molecular docking studies, compound 3a displayed important interactions compared to other active derivatives. Molecular dynamics studies are important to see the stability of the complex formed by ligand and protein. RMSD, RMSF ang Rg parameters were calculated via dynamic studies. In conclusion, compound 3a may be a potential AChE enzyme inhibitor with its strong inhibitory potential and behavior in silico.Keywords
This publication has 23 references indexed in Scilit:
- Synthesis of new donepezil analogues and investigation of their effects on cholinesterase enzymesEuropean Journal of Medicinal Chemistry, 2016
- Alzheimer's diseaseNature Reviews Disease Primers, 2015
- Structures of Human Acetylcholinesterase in Complex with Pharmacologically Important LigandsJournal of Medicinal Chemistry, 2012
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Propagation of Tau Misfolding from the Outside to the Inside of a CellJournal of Biological Chemistry, 2009
- Genetics of Alzheimer's Disease: A Centennial ReviewNeurologic Clinics, 2007
- A “mitochondrial cascade hypothesis” for sporadic Alzheimer's diseaseMedical Hypotheses, 2004
- SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor proteinNature Neuroscience, 1999
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Anti‐inflammatory agents as a therapeutic approach to Alzheimer's diseaseNeurology, 1992